HD Labs Tirzepatide 60mg

HD Labs Tirzepatide 60mg

HD Labs Tirzepatide 60mg is a research-grade peptide reference material featuring tirzepatide, a synthetic peptide studied for its activity at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor.

The product shown is labelled as 60mg per vial and is presented by HD Labs as a peptide research product.

Research Overview

Tirzepatide is notable within peptide research because it interacts with two incretin-related receptor pathways rather than targeting GLP-1 alone. FDA clinical pharmacology information describes tirzepatide as a GIP and GLP-1 receptor agonist and reports effects involving appetite regulation, insulin secretion, glucagon secretion and gastric emptying.

This dual-receptor activity has made tirzepatide an important subject of ongoing research involving:

• GIP receptor signalling
• GLP-1 receptor signalling
• Metabolic regulation
• Glucose-dependent insulin secretion
• Glucagon regulation
• Appetite and energy-intake pathways
• Gastric-emptying research
• Body-composition and metabolic research